تقرير
Response to Letter to the Editor: Self-Identified Black Race as a Risk Factor for Intraocular Pressure Elevation and Iritis Following Prophylactic Laser Peripheral Iridotomy.
العنوان: | Response to Letter to the Editor: Self-Identified Black Race as a Risk Factor for Intraocular Pressure Elevation and Iritis Following Prophylactic Laser Peripheral Iridotomy. |
---|---|
المؤلفون: | Adetunji MO; Scheie Eye Institute., Ying GS; Scheie Eye Institute.; Center for Preventive Ophthalmology and Biostatistics, Department of Ophthalmology University of Pennsylvania Perelman School of Medicine, Philadelphia, PA., Cui QN; Scheie Eye Institute. |
المصدر: | Journal of glaucoma [J Glaucoma] 2022 Sep 01; Vol. 31 (9), pp. e88-e89. Date of Electronic Publication: 2022 Jul 07. |
نوع المنشور: | Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Letter; Comment |
اللغة: | English |
بيانات الدورية: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9300903 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-481X (Electronic) Linking ISSN: 10570829 NLM ISO Abbreviation: J Glaucoma Subsets: MEDLINE |
أسماء مطبوعة: | Publication: <2015- > : Philadelphia, PA : Wolters Kluwer Health, Inc. Original Publication: New York, N.Y. : Raven Press, c1992- |
مواضيع طبية MeSH: | Iritis* , Laser Therapy*, Humans ; Intraocular Pressure ; Lasers ; Risk Factors ; Tonometry, Ocular |
مستخلص: | Competing Interests: Disclosure: The authors declare no conflict of interest. |
التعليقات: | Comment on: J Glaucoma. 2022 Apr 1;31(4):218-223. (PMID: 35131983) Comment on: J Glaucoma. 2022 Sep 1;31(9):e87. (PMID: 35797696) |
References: | Adetunji MO, Meer E, Whitehead G, et al. Self-identified Black Race as a risk factor for intraocular pressure elevation and iritis following prophylactic laser peripheral iridotomy. J Glaucoma. 2022;31:218–223. Thompson AC, Vu DM, Cowan LA, et al. Factors associated with interventions after laser peripheral iridotomy for primary angle-closure spectrum diagnoses. Ophthalmol Glaucoma. 2019;2:192–200. |
معلومات مُعتمدة: | L30 EY029353 United States EY NEI NIH HHS; R25 HL084665 United States HL NHLBI NIH HHS; P30 EY001583 United States EY NEI NIH HHS; K12 EY015398 United States EY NEI NIH HHS; K08 EY029765 United States EY NEI NIH HHS |
تواريخ الأحداث: | Date Created: 20220707 Date Completed: 20220908 Latest Revision: 20240216 |
رمز التحديث: | 20240216 |
مُعرف محوري في PubMed: | PMC9437124 |
DOI: | 10.1097/IJG.0000000000002074 |
PMID: | 35797698 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1536-481X |
---|---|
DOI: | 10.1097/IJG.0000000000002074 |